Biomarkers associated with 30-day readmission and mortality after pediatric congenital heart surgery.

Devin M ParkerAllen D EverettMeagan E StablerLuca VricellaMarshall L JacobsJeffrey P JacobsHeather Thiessen-PhilbrookChirag R ParikhJeremiah R Brown

Published in: Journal of cardiac surgery (2019)

Elevated pre-and postoperative levels of ST2 and Galectin-3 are associated with increased risk of readmission or mortality after pediatric heart surgery. These clinically available biomarkers can be used for improved risk stratification and may guide improved patient care management.

Keyphrases

minimally invasive
coronary artery bypass
surgical site infection
heart failure
patients undergoing
atrial fibrillation
coronary artery disease
acute coronary syndrome